Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag:  a case report 

BACKGROUND: Pulmonary arterial hypertension is a progressive, debilitating condition characterized by increased resistance in the pulmonary arterial circulation. Current treatments for pulmonary arterial hypertension include endothelin receptor antagonists such as bosentan, sitaxentan, ambrisentan,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lattanzio, Mariangela, Ferrari, Marco, Martini, Stefano, Ceriani, Francesca, Imporzani, Andrea, Marino, Franca, De Ponti, Roberto, Cosentino, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578229/
https://www.ncbi.nlm.nih.gov/pubmed/36258237
http://dx.doi.org/10.1186/s13256-022-03571-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578229/
https://www.ncbi.nlm.nih.gov/pubmed/36258237
http://dx.doi.org/10.1186/s13256-022-03571-9

Ejemplares similares